4.6 Article

Anticarin β Inhibits Human Glioma Progression by Suppressing Cancer Stemness via STAT3

期刊

FRONTIERS IN ONCOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2021.715673

关键词

natural product; glioma; apoptosis; DNA damage; stemness

类别

资金

  1. National Natural Science Foundation of China [81903666]
  2. Science and Technology Department of Yunnan Province [202101AT070301, 202002AA100007, 2019ZF003]

向作者/读者索取更多资源

The study demonstrated that anticarin beta can effectively suppress proliferation and induce apoptosis in glioma cells, decrease stemness gene expression, induce DNA damage, and eventually lead to apoptosis by regulating oncogene expression. Overall, anticarin beta shows promising potential as an inhibitor for malignant glioma.
Glioma is the most common form of malignant brain cancer. It is very difficult to cure malignant glioma because of the presence of glioma stem cells, which are a barrier to cure, have high tumorigenesis, associated with drug resistance, and responsible for relapse by regulating stemness genes. In this study, our results demonstrated that anticarin beta, a natural compound from Antiaris toxicaria, can effectively and selectively suppress proliferation and cause apoptosis in glioma cells, which has an IC50 that is 100 times lower than that in mouse normal neural stem cells. Importantly, cell sphere formation assay and real time-quantitative analysis reveal that anticarin beta inhibits cancer stemness by modulating related stemness gene expression. Additionally, anticarin beta induces DNA damage to regulate the oncogene expression of signal transducer and activator of transcription 3 (STAT3), Akt, mitogen-activated protein kinases (MAPKs), and eventually leading to apoptosis. Furthermore, anticarin beta effectively inhibits glioma growth and prolongs the lifts pan of tumor-bearing mice without systemic toxicity in the orthotopic xenograft mice model. These results suggest that anticarin beta is a promising candidate inhibitor for malignant glioma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据